The Art of Doing Nothing: When 'Less is More' in Medical Decisions
"Why standing your ground and resisting the urge to over-treat can be the best medicine."
In the high-stakes world of soccer, penalty kicks are moments of intense pressure. Goalkeepers often dive acrobatically, yet research suggests they might block more goals by simply standing still in the center. The fear of appearing inactive, however, often drives them to dive, even if it's the wrong choice.
This dilemma mirrors a challenge in medicine: the pressure to act, to test, to treat—even when restraint might be the better course. The medical community often fears missing a diagnosis more than the potential harm of unnecessary interventions. This bias can lead to a cascade of tests and treatments that ultimately do more harm than good, such as the overuse of broad-spectrum antibiotics leading to Clostridium difficile infections.
Patients often equate more care with better care, further incentivizing physicians to lower their thresholds for testing and treatment. This article explores the concept of 'less is more' in medical decision-making, arguing that sometimes, standing your ground is the most effective approach.
Data Everywhere, Understanding Scarce
Statistics now steer patient care at every level, but the influence of data depends heavily on how it is gathered and read. A systematic review on the PMC database focuses specifically on how data-driven decision making influences patient care, grounded in a defined data-sources and search-strategy methodology. Federal repositories such as HealthData.gov pool health and human services data for research, app development, and data visualizations, while the CDC's overdose-prevention resources stress that accessible data can equip public health professionals to implement targeted interventions. Yet a Patient Power guide warns that medical statistics are hard to understand and often get misinterpreted, producing unnecessary anxiety or misplaced confidence about individual risk.
Shared Decision-Making and Its Limits
The accepted standard for routine decisions is Shared Decision-Making (SDM), a collaborative process in which physicians integrate scientific evidence with patients' goals, preferences, and values — an approach that contrasts with traditional methods and enhances patient engagement. The standard is not uniformly achievable: overviews of medical decision making note its particular importance in emergency situations and catalog the limitations clinicians face in practice. Nowhere are those limits starker than at the end of life, where a BMC review examines the decision-making process around treatment limitation in family and emergency medicine and the associated ethical considerations. Complementing it, a qualitative study in JAMA Network Open describes the types of decision-making approaches clinicians report using to limit potentially nonbeneficial life-prolonging interventions.
A Century of Autonomy
Medical decision making has deep roots: a Springer handbook chapter traces the evolution of Shared Decision-Making from origins in the early 20th-century concept of informed consent to its current status, paying particular attention to the key actors, patients and physicians. Parallel to that clinical evolution, the past 100 years saw landmark US legal cases shape patient autonomy, emphasizing individuals' rights to make their own decisions about medical treatment. Autonomy thinking has even extended to the level of cells—Harvard Medical School's Timeline of Discovery recounts how single-cell sequencing, developed at the School, traced the fates of individual cells over the first 24 hours of an embryo's life and generated a detailed roadmap of which genes are switched on in the earliest stages.
The Perils of Reflexive Medicine: Blood Cultures as a Case Study
Consider the routine practice of ordering blood cultures for febrile patients. While fever often triggers immediate action, it's a surprisingly poor predictor of bacteremia in hospitalized individuals. This reflexive response to fever can lead to unnecessary testing, increased costs, and the overuse of antibiotics.
- Unnecessary antibiotic use
- Increased hospital stays
- Higher healthcare costs
New Evidence, New Rigor
Recent research is refining how medical decisions are studied, and some older assumptions are being tested. The Journal Medical Decision Making (MDM), a COPE member journal of the Society for Medical Decision Making, notes in its current issue that time-to-event outcomes from randomized controlled trials are often communicated without clearly conveying how treatment effects evolve over time, limiting clinicians' ability to interpret results and support patient decision making. A randomized clinical trial published in JAMA Network Open challenges the suggestion that physicians experience cognitive bias in decision-making situations that offer multiple treatment alternatives. Meanwhile, a systematic review of decision fatigue—a widely invoked but loosely defined concept—proposes a new definition for greater conceptual clarity and more consistent operationalisation, calling for future studies to develop and test different theoretical explanations.
When Less Doesn't Win
The case for doing less is not without failures, and it is worth being candid about its limits. Efforts to cut low-value care can stall in practice, and some attempts at watchful waiting have been reversed or regretted, though the evidence is mixed. Patients occasionally read the withdrawal of a test or treatment as abandonment rather than restraint, and clinicians may worry about missing a serious diagnosis. The honest conclusion, based on accumulated clinical experience, is that restraint only works when it is paired with judgment, continuity, and clear communication rather than applied as a blanket rule.
Active Steps Versus Watchful Waiting
Comparisons between active treatment and deliberate inaction are rarely clean, and neither approach dominates across conditions. Aggressive strategies can yield measurable benefits but carry costs, side effects, and treatment burden, while watchful waiting conserves resources and avoids harm but risks delaying intervention. How the trade-off is framed matters, since outcomes are measured differently and benefits often accrue over long time horizons. In most cases, the better choice depends less on the category of approach and more on the patient's condition, values, and the quality of the underlying evidence.
Embracing Thoughtful Inaction
The decision to culture requires reflection, not reflex. In cases like community-acquired pneumonia (CAP), routine blood cultures have shown limited value, rarely changing patient management. A more selective approach, focusing on high-risk subgroups, is more effective.
Formal Models, Limited Judgment
Clinical decisions involve constant trading of benefits and harms, and experts note that this is frequently done through global, implicit judgments rather than explicit reasoning. A Users' Guide to Medical Decision Analysis in Mayo Clinic Proceedings argues that decision analysis makes this process more explicit, reproducible, and evidence-based, and it walks clinicians through the anatomy of a decision tree so they can critically appraise published analyses and the guidelines built on them. Yet the expertise those models depend on remains loosely regulated: a BMC Medical Research Methodology study finds that the use of Expert Opinion in clinical guidelines is highly variable and lacks standardization, with no clear, universally accepted definition. In short, even well-intentioned 'less is more' advice ultimately leans on judgment that is only partly formalized.
Prediction as the Path to Restraint
The next frontier for doing less in medicine will likely be better prediction—using improved data and modeling to identify who genuinely benefits from treatment and who can safely skip it. Sharper decision analytics and evidence from real-world settings could make watchful waiting more defensible by quantifying long-term benefits and harms. Cultural shifts that reframe non-intervention as an active, planned choice rather than a passive default may be just as important. Still, that future depends on trust, transparency, and evidence that does not yet fully exist, so these possibilities should be read as directions rather than guarantees.
A System Built to Act
Restraint faces structural headwinds that go far beyond any single clinician's judgment. Reimbursement models, defensive medicine, performance metrics, and patient expectations all tend to reward action, making the least-intervention path harder to sustain. Behavior and organizational incentives can override even well-founded recommendations. Systemic constraints—how care is financed, measured, and talked about—may ultimately do as much to decide when less truly is more as the clinical evidence itself.
Families, Fragmentation, and Real-World Evidence
In real life, decisions rarely follow clean algorithms. In a case study published on the Practical Bioethics site, a patient named Sarah initially has decision-making capacity and makes treatment and goals-of-care choices with her husband and two adult children—yet inconsistently, depending on who is present in the room. The Hastings Center's clinical ethics series takes on an even harder scenario: an unrepresented, incapacitated patient with delusions and no surrogate decision-maker who refuses all treatment, even after a game-changing finding. Evidence from the field is equally uneven—a review notes that pragmatic trials conducted in real-world settings are seen as an important source of actionable, relevant evidence, yet limited information exists on the practical experience of generating it, and a global study collecting case studies from four South American countries found real-world evidence use inconsistent across regions, providers, and insurance schemes, hampered by fragmentation, lack of stewardship, and limited resources.
Resisting the urge to reflexively act can be challenging, especially when facing pressure from colleagues or ingrained protocols. It requires a commitment to personalized medicine, carefully weighing the risks and benefits of each intervention.
By embracing thoughtful inaction, physicians can improve patient outcomes, reduce healthcare costs, and move away from a culture of reflexive medicine. As Martin Gabel wisely advised, 'Don't just do something, stand there!'